PHARMAESSENTIA CORP innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	China	11
#2	Taiwan	10
#3	EPO (European Patent Office)	9
#4	Australia	7
#5	WIPO (World Intellectual Property Organization)	7
#6	Brazil	6
#7	Republic of Korea	6
#8	United States	5
#9	Canada	4
#10	EAPO (Eurasian Patent Organization)	4
#11	Mexico	4
#12	Argentina	3
#13	Chile	3
#14	Hong Kong	3
#15	New Zealand	3
#16	South Africa	3
#17	Israel	2
#18	Malaysia	2
#19	Singapore	2
#20	Ukraine	2
#21	Hungary	1
#22	Japan	1
#23	Morocco	1
#24	Philippines	1
#25	Serbia	1
#26	Tunisia	1

#	Industry
#1	Pharmaceuticals
#2	Biotechnology
#3	Organic fine chemistry
#4	Macromolecular chemistry and polymers

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Peptides
#4	Sugars
#5	Macromolecular compounds compositions
#6	Acyclic or carbocyclic compounds

Publication	Filing date	Title
BR112017009193A2	2015-11-06	method of treating an infectious disease, cancer, or myeloproliferative disease in an individual; method of treating a myeloproliferative disease in an individual; and; type i interferon
TW201331219A	2013-01-03	Novel synthesis of 5-deoxy-5'-fluorocytidine compounds
TW201309716A	2012-03-30	Synthesis of β-nucleosides
KR20120110105A	2010-12-09	Therapeutic use of protein-polymer conjugates
NZ591167A	2009-07-31	Peptide-polymer conjugates
TW200932754A	2008-11-06	Novel synthesis of β-nucleosides
WO2009046080A1	2008-10-01	N-terminal modified interferon-alpha
CL2008002399A1	2008-08-14	Substantially pure conjugate having a polymeric portion, a protein portion (interferon alpha 2b) and an aliphatic binder of 1 to 10 carbon atoms, useful in the treatment of hepatitis b or c.
WO2009006579A1	2008-07-03	Peptide-polymer conjugates
CN101405024A	2006-12-29	Drug-polymer conjugates
WO2006119347A1	2006-05-02	STEREOSELECTIVE SYNTHESIS OF β-NUCLEOSIDES
CN101076536A	2005-07-29	Stereoselective synthesis of beta-nucleosides